FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 344:418-423 February 8, 2001 Number 6 Next

	Full Text PDF Editorial by Bonis, P. A.L. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Chronic obstruction of the common bile duct may cause hepatic fibrosis and secondary biliary cirrhosis.

Methods We studied liver-biopsy specimens from 11 patients with chronic stenosis of the common bile duct due to chronic pancreatitis; all the patients had undergone liver biopsy before or at the time of surgical biliary decompression and underwent a subsequent liver biopsy for various clinical reasons. The patients were followed as part of a prospective study of 501 patients who had been treated for chronic pancreatitis. Two pathologists, who were unaware of the sequence of specimens, graded fibrosis on a scale of 0 (none) to 3 (cirrhosis).

Results The 11 patients were all men. Chronic pancreatitis was due to alcohol abuse in 10 of the men; 1 had idiopathic disease. The median age at diagnosis was 38 years. The median interval between the first and second liver biopsies was 2.5 years (range, 0.3 to 9.0). The two patients who had restenosis of the biliary anastomosis were excluded from the analysis of fibrosis. In the group of nine patients without restenosis, the second specimen showed significant improvement in fibrosis (P=0.01). The fibrosis improved by two grades in two patients and by one grade in four patients; in three patients, the grade did not change. The pathologists agreed on the grading of specimens from 10 of the 11 patients.

Conclusions In patients with chronic pancreatitis and stenosis of the common bile duct, liver fibrosis may regress after biliary drainage.

Source Information

From Fédération Médico-Chirurgicale d'Hépato-Gastroentérologie, Service de Gastroentérologie (P.H., D.O.T., A.R., P.B., P.R., P.L.), Service d'Anatomie Pathologique (A.C., J.F.F., C.D.), Service de Chirurgie Digestive (A.S., J.B.), and Service d'Hépatologie (D.V.), Hôpital Beaujon, Clichy, France.

Address reprint requests to Dr. Ruszniewski at Fédération Médico-Chirurgicale d'Hépato-Gastroentérologie, Hôpital Beaujon, AP-HP, 92118 Clichy CEDEX, France, or at philippe.ruszniewski{at}bjn.ap-hop-paris.fr.

Full Text of this Article

This article has been cited by other articles:

• Hsu, R.-B., Chang, C.-I, Lin, F.-Y., Chou, N.-K., Chi, N.-H., Wang, S.-S., Chu, S.-H. (2008). Heart transplantation in patients with liver cirrhosis.. Eur. J. Cardiothorac. Surg. 34: 307-312 [Abstract] [Full Text]  
• Williams, E J, Green, J, Beckingham, I, Parks, R, Martin, D, Lombard, M (2008). Guidelines on the management of common bile duct stones (CBDS). Gut 57: 1004-1021 [Abstract] [Full Text]  
• Munoz-Luque, J., Ros, J., Fernandez-Varo, G., Tugues, S., Morales-Ruiz, M., Alvarez, C. E., Friedman, S. L., Arroyo, V., Jimenez, W. (2008). Regression of Fibrosis after Chronic Stimulation of Cannabinoid CB2 Receptor in Cirrhotic Rats. J. Pharmacol. Exp. Ther. 324: 475-483 [Abstract] [Full Text]  
• Church, N I, Pereira, S P, Churchill, D, Cairns, S, Hatfield, A R W, Webster, G J M (2007). Chronic pancreatitis: diagnosis and management of complications. Gut 56: 1189-1190 [Full Text]  
• Siegmund, S. V., Qian, T., de Minicis, S., Harvey-White, J., Kunos, G., Vinod, K. Y., Hungund, B., Schwabe, R. F. (2007). The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species. FASEB J. 21: 2798-2806 [Abstract] [Full Text]  
• Rouviere, O., Yin, M., Dresner, M. A., Rossman, P. J., Burgart, L. J., Fidler, J. L., Ehman, R. L. (2006). MR Elastography of the Liver: Preliminary Results.. Radiology 240: 440-448 [Abstract] [Full Text]  
• Popov, Y., Patsenker, E., Bauer, M., Niedobitek, E., Schulze-Krebs, A., Schuppan, D. (2006). Halofuginone Induces Matrix Metalloproteinases in Rat Hepatic Stellate Cells via Activation of p38 and NF{kappa}B. J. Biol. Chem. 281: 15090-15098 [Abstract] [Full Text]  
• Kang, J. S., Morimura, K., Salim, E. I., Wanibuchi, H., Yamaguchi, S., Fukushima, S. (2005). Persistence of Liver Cirrhosis in Association with Proliferation of Nonparenchymal Cells and Altered Location of {alpha}-Smooth Muscle Actin-Positive Cells. Toxicol Pathol 33: 329-335 [Abstract] [Full Text]  
• Negi, S. S., Sakhuja, P., Malhotra, V., Chaudhary, A. (2004). Factors Predicting Advanced Hepatic Fibrosis in Patients With Postcholecystectomy Bile Duct Strictures. Arch Surg 139: 299-303 [Abstract] [Full Text]  
• Greenberger, N. J. (2003). Update in Gastroenterology. ANN INTERN MED 138: 45-53 [Full Text]  
• Muretto, P., Angelucci, E., Lucarelli, G. (2002). Reversibility of Cirrhosis in Patients Cured of Thalassemia by Bone Marrow Transplantation. ANN INTERN MED 136: 667-672 [Abstract] [Full Text]  
• Bonis, P. A.L., Friedman, S. L., Kaplan, M. M. (2001). Is Liver Fibrosis Reversible?. NEJM 344: 452-454 [Full Text]